Patient perspectives on GLP-1 receptor agonists: Insights from online forums
Vegan, non-GMO, made in the USA
Bit of Background These new classes of antiobesity medications (ie, the GLP-1 agonists and dual agonists), referred to in this article as weight management medications, arent really new.1-4 The basic science and pharmaceutical research and development to bring these to market began more than two decades ago when two scientists, Matthias Tschop, MD, and Richard DiMarchi, PhD, hypothesized that the actions of various gut hormones may offer safe and unprecedented weight loss
Body composition assessments through DEXA scanning, bioelectrical impedance, or even simple tape measurements of waist and limb circumferences offer more meaningful progress tracking
Improves Energy Production